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Abstract
Background: Though hemodialysis (HD) acutely improves cardiac function, the impact of
background diseases like coronary artery disease (CAD) and Type 2 diabetes (DM) in the setting
of end-stage renal disease (ESRD) is not known. Tissue velocity echocardiography (TVE) offers a
fast choice to follow changes in myocardial function after HD in ESRD with concomitant DM and
/or CAD.
Methods: 46 subjects (17 with ESRD, Group 1; 15 with DM, Group 2; 14 with DM+CAD, Group
3) underwent standard and TVE prior to and shortly after HD. Besides standard Doppler variables,
regional myocardial systolic and diastolic velocities, as well as systolic strain rate were post
processed.
Results: Compared with pre-HD, post-HD body weight (kg) significantly decreased in all the three
groups (51 ± 9 vs. 48 ± 8, 62 ± 10 vs.59 ± 10, and 61 ± 9 vs. 58 ± 9 respectively; all p < 0.01). Left
ventricular end diastolic dimensions (mm) also decreased post- HD (46 ± 5 vs. 42 ± 7, 53 ± 7 vs.
50 ± 7, 51 ± 7 vs. 47 ± 8 respectively; all p < 0.01). Regional longitudinal peak systolic velocity in
septum (cm/s) significantly increased post-HD in Group 1(5.7 ± 1.6 vs. 7.2 ± 2.3; p < 0.001) while
remained unchanged in the other two groups. Similar trends were noted in other left ventricular
walls. When the myocardial velocities (cm/s) were computed globally, the improvement was seen
only in Group 1 (6.3 ± 1.5 vs. 7.9 ± 2.0; p < 0.001). Global early regional diastolic velocity (cm/s)
improved in Group 1, remained unchanged in Group 2, while significantly decreased in Group 3(-
5.9 ± 1.3 vs. -4.1 ± 1.8; p < 0.01). Global systolic strain rate (1/sec) increased in the first 2 Groups
but remained unchanged (-0.87 ± 0.4 vs. -0.94 ± 0.3; p = ns) in Group 3.
Conclusion: A single HD session improves LV function only in ESRD without coexistent DM and/
or CAD. The present data suggest that not only dialysis-dependent changes in loading conditions
but also co-existent background diseases determine the myocardial response to HD.
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Patients with Type 2 diabetes mellitus (DM) of long dura-
tion frequently suffer from end-stage renal disease (ESRD)
and a great majority of them also have coexistent coronary
artery disease (CAD) [1,2]. Patients with primary ESRD
are at risk of having a coronary event as well and often die
of cardiac causes [3-5]. Detailed mechanisms behind car-
diac deaths have been relatively well described, but exact
changes in the regional contractile behaviors of the left
ventricle (LV) are not clearly established in ESRD, particu-
larly during on-going renal replacement therapy such as
hemodialysis (HD), a procedure destined to temporarily
remove excess fluids and toxins.
Though it has been already demonstrated in patients
undergoing HD that concomitant changes in the TVE var-
iables are load dependant [6-9], it is however still not
known whether ESRD with coexistent DM and/or CAD,
i.e., conditions in which regional myocardial systolic and
diastolic velocities are already diminished [10-13], have
differing myocardial response following dialysis-depend-
ent acute changes in preload.
Therefore, in this study, we have tested the hypothesis that
longitudinal myocardial functions as assessed by TVE in
response to HD are quantitatively different in differing




The number of study subjects was 46. Patients with pri-
mary myocardial disease, significant pericardial disease,
significant valvular disease or arrhythmias were excluded.
Diagnoses of the illnesses were defined by standard crite-
ria, medication and treatment history and from the hospi-
tal database. Diagnosis of CAD was on the basis of clinical
history, findings of definite ECG changes of ischemia or
previous myocardial infarction, echocardiographic find-
ings of regional wall motion abnormality (n = 9) and
those having angiographic evidence of significant coro-
nary artery disease (n = 5). All biochemical analyses were
done prior to HD, using a standard spectrophotometer.
The Institutional Review Board of Bhagwan Mahavir Jain
Heart Centre, Bangalore, India, approved the study proto-
col. All the study subjects gave their informed consent to
participate.
Standard echocardiography protocol
Echocardiography was performed using a VIVID 5 equip-
ment (GE Vingmed, Horten, Norway) with a preinstalled
Echopac 6.3.4 software program. A 2.5 MHz probe was
used for image acquisition. The images were acquired in
parasternal long- and short-axis and in apical 2-, 3-, and 4-
chamber projections. LV dimensions and wall thicknesses
were measured by M-mode in the parasternal long-axis
views. Mitral inflow velocities were measured by conven-
tional pulsed wave Doppler, by positioning the sample
volume at the level of the tips of mitral leaflets in the api-
cal 4-chamber views. The peak early (E) and late (A)
diastolic velocities, and E/A ratio were measured. 2-D LV
ejection fraction was measured by modified Simpson's
approach. All 2-D and M-mode measurements were made
according to the American Society of Echocardiography
guidelines.
Tissue velocity echocardiography
Digitally stored cine loops during three consecutive heart
cycles were analysed offline using Echopac 6.3.0 software
(GE Vingmed, Horten, Norway). The LV long-axis
regional function was assessed from the apical views from
which four basal segments (septum, lateral, inferior, and
anterior) were analysed. The cursor was placed in the
basal segment so as to exclude the mitral annulus. A typi-
cal velocity profile could be obtained by positioning the
sample volume in any of the basal segments. Peak systolic
(PSV), early diastolic (E'), and late diastolic (A') myocar-
dial velocities (cm/sec) were measured at the peaks of the
respective waves on the myocardial velocity curves in the
individual LV walls (Figure 1). The corresponding global
variables were measured by taking average of the 4 LV
bases. The LV short-axis systolic and diastolic functions
were assessed from the parasternal short-axis images, from
which only the mid posterior segments (parasternal short-
axis image) were analysed in order to compute radial data.
Isovolumic contraction (IVCT) and relaxation (IVRT)
times as well as ejection (ET) times were also measured
according to methods described by Lind et al [14]. Filling
time (FT) was measured from the end of IVRT to the
beginning of IVCT. The myocardial wall displacement
(mm) in the long- and short-axis was obtained by auto-
mated temporal integration of the velocity profile during
systole (Figure 1). E/E' was measured from the septal and
lateral annulus from the apical 4-chamber projection. LV
myocardial performance index, Tei index [15], was
defined as the sum of IVCT and IVRT divided by ejection
time using the color Doppler. Global Tei index was calcu-
lated by taking the average data from 4 LV bases. Images
were stored at an average frame rate of 130 s-1 for post
processing.
Strain rate imaging
Strain represents deformation of an object (in this case the
myocardial wall) and is often expressed in percentage of
change from end-diastolic dimension [16]. Positive strain
represents lengthening or stretching while negative strain
is shortening or compression. Strain rate (SR) is the
instantaneous strain per unit time (cm/s/cm, or 1/sec)
and has the same direction as the strain, i.e. negative strainPage 2 of 9
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ening (Figure 1, lower panel). Strain rate therefore repre-
sents velocity of regional myocardial deformation,
thereby also reflecting myocardial contraction when
measured at peak systole. To calculate strain rate the area
of interest along the sample scale was chosen to be ≈ 15
mm since this appears to provide the best signal to noise
ratio. The longitudinal basal, mid and apical segments of
septum, lateral, inferior and anterior walls were averaged
to assess global strain rate. Radial strain rate was calcu-
lated from the LV posterior wall in the short axis projec-
tion. Similar frame rates used for velocity data were also
used to measure strain rate.
Hemodialysis
All patients were on maintenance HD, done twice weekly.
Duration of maintenance HD varied from 10 months to 7
years. Echocardiography was done within 60 minutes of
pre- and postdialysis. Hemodialysis was performed using
Fresemins-76 dialyser with dialysate flow rate of 500 ml/
Upper left: A typical color-Doppler velocity profile obtained by positioning the sample volume in the septum baseFigu e 1
Upper left: A typical color-Doppler velocity profile obtained by positioning the sample volume in the septum base. S1 = isovolu-
mic contraction velocity in the first positive peak, PSV = peak systolic velocity. IVCT and IVRT respectively are isovolumic con-
traction and relaxation times, E'and A'are respectively early and late diastolic velocities. The velocity profile is accompanied by 
an ECG signal. Upper right. A systolic displacement image, obtained by integration of the respective velocity profile during sys-
tole that provides amplitude of total displacement (usually ≥ 12 mm in healthy individuals). Lower panel. Strain rate imaging in 
which the white arrow indicates peak systolic strain rate obtained by spatial differential of velocities at two points divided by 
the distance between them. In our laboratory the insonation distance of approximately 15 mm provides a favorable signal-to-
noise ratio [27].Page 3 of 9
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flow of 500 ml/min and an average blood flow of 250 ml/
min.
Coronary angiography
Coronary angiographies were done using the Judkins
technique. Significant stenosis was defined as >70 %
intra-luminal obstruction either visually or quantitatively
by coronary angiography.
Statistical methods
Data are expressed as mean ± SD. One-way ANOVA fol-
lowed by Scheffe's test was performed to compare the dif-
ferences among the three groups. Paired t test was
performed to compare pre-and post-HD data within
groups. A PC-based version of STATISTICA version 6.0
was used for data analyses. Intra-observer variation was
similar to our previous study [11]. All continuous varia-
bles are expressed as mean ± SD. A p value of <0.05 was
considered statistically significant.
Results
Of the study subjects 31 were males and 15 females. The
age (years) of the subjects respectively in the 3 groups
were 40 ± 16, 57 ± 7, and 56 ± 9 (p < 0.05 for Group 1 vs.
others). The study subjects were non-consecutively
selected and divided as Group 1: ESRD due to primary
renal disease (n = 17), Group 2: ESRD+DM (n = 15), and
Group 3: ESRD+DM+CAD (n = 14). Patients with primary
ESRD had polycystic kidney disease, IgA nephropathy,
focal segmental glomerulosclerosis, or crescent glomeru-
lonephritis. Remaining clinical characteristics of the study
population are given in Table 1.
Table 2 provides the biochemical data that show plasma
glucose being the lowest and serum HDL highest in the
ESRD group while serum creatinine was the lowest in
ESRD+DM+CAD group (all relevant p < 0.05). Blood
hemoglobin levels were equally low in all the groups. Ele-
vated glucose level was present in the DM groups while
serum cholesterol and triglycerides were non-significantly
elevated only in the ESRD+DM+CAD group.
Table 3 shows that there were no changes in the heart rate
(R-R interval) and systolic and diastolic blood pressures at
pre- or post-HD, but body weight decreased significantly
in all the groups at post-HD. LV hypertrophy at predialysis
was seen in 7 ESRD, 10 ESRD+DM, and 12
ESRD+DM+CAD subjects, respectively, with no signifi-
cant change at post-HD. 2-D obtained LV ejection fraction
(>40% in all the 3 groups) did not show any significant
changes within the groups at pre- and post-HD. LV inter-
nal dimensions showed significant decrease in all the
groups post- HD. The velocity of early diastolic filling (E)
decreased in ESRD and ESRD+DM+CAD groups while
deceleration time (DT) increased in ESRD+DM+CAD
group after dialysis. E/A ratio obtained from the standard
transmitral Doppler was lower in all the groups at post
HD (all p < 0.05).
Table 1: Clinical characteristics of the study subjects
Average age of the patients (years) 51 ± 14
Average body weight (kg) 58 ± 6
Number of male/female pts 31/15
Average systolic BP (mmHg) 146 ± 11
Average diastolic BP (mmHg) 87 ± 8
Duration of DM 14 ± 6 years
Number of DM subjects receiving insulin 9
Number of patients receiving insulin plus OHD 37
OHD = Oral hypoglycaemic drugs; DM= Type 2 diabetes mellitus
Table 2: Biochemical data in the three study groups at pre-HD
ESRD Group 1 (n = 17) ESRD+DM Group 2 (n = 15) ESRD+DM+CAD Group 3 (n = 
14)
Blood Urea Nitrogen (mg/dl) 152.33 ± 81.94 112.29 ± 24.64 107.07 ± 32.58
S.Creatinine (mg/dl) 9.42 ± 2.53 9.0 ± 1.42 7.46 ± 1.94 *
Hemoglobin (mg/dl) 7.97 ± 1.13 8.73 ± 0.87 8.05 ± 1.33
S.Glucose (mg/l) 101.00 ± 9.44† 169.95 ± 74.06 161.10 ± 67
S.Sodium (mmol/l) 139.89 ± 5.19 131.72 ± 35.31 140.15 ± 3.29
S.Potassium (mmol/l) 5.41 ± 0.70 5.27 ± 0.94 5.64 ± 0.74
S.Calcium (mg/dl) 8.24 ± 0.79 7.85 ± 0.72 8.02 ± 0.58
S.Phosphate (mg/dl) 5.31 ± 1.68 5.22 ± 1.15 4.41 ± 1.02
S. Cholesterol (mg/dl) 176.06 ± 19.90 183.85 ± 35.64 238.25 ± 59.99
S.Triglycerides (mg/dl) 148.13 ± 24.26 155.77 ± 29.97 172.25 ± 29.59
S.HDL (mg/dl) 45.94 ± 5.97‡ 36.77 ± 6.64 40.67 ± 4.25
S.LDL (mg/dl) 84.06 ± 15.46 95.77 ± 27.06 108.00 ± 20.63
Data Data are means ± SD. Group comparisons were made using one way ANOVA followed by Scheffe's test. * p < 0.05 Group 1 vs. Group 3; † p 
< 0.01 Group 1 vs. Group 2 and Group 3; ‡ p < 0.01 Group 1 vs. Group 2. HDL = high density lipoprotein; LDL = low density lipoprotein. S = 
SerumPage 4 of 9
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with between- groups comparisons of LV regional data
pre- and post- HD. At pre-HD there were no significant
differences of PSV in the septum among the patient
groups, but in the other LV walls PSV was significantly
higher in the ESRD group than in the other two groups
(all p < 0.05). E' velocity in the ESRD group was higher
only in the anterior and the inferior walls when compared
with the other groups. A' velocity in the ESRD group was
higher only in the lateral wall in comparison with the
other groups. LV displacement at predialysis was higher in
ESRD group in the inferior wall when compared with
ESRD+DM+CAD group and in the anterior wall it was
higher compared with the other 2 groups (all p < 0.05).
Following HD (Table 4, lower panel), the PSV and E' were
significantly higher in the ESRD group compared with the
other 2 groups, while A' and longitudinal systolic dis-
placement in the ESRD group were significantly higher in
ESRD group compared with ESRD +DM+CAD in the LV
septum.
Figure 2 shows comparisons of pre- and post-HD effects
on global LV systolic and diastolic functions. The global
PSV was significantly increased in the ESRD group after
dialysis but remained unchanged in the other two groups.
The global E' velocity was increased in ESRD group, but
decreased in ESRD+DM+CAD group while the global A'
velocity was increased in the ESRD and ESRD+DM
groups.
Figure 3 shows global LV strain rate pre- and post-HD.
While subjects with ESRD as well as those with only DM
had increased strain rate following dialysis indicating
increased myocardial deformation velocity, the
ESRD+DM+CAD group did not show any significant
change.
Radial TVE data
Radial images at pre-HD did not show any significant dif-
ference among the groups. Post-HD measurements how-
ever revealed PSV, E' velocity and SR increased in the
ESRD group, as they were seen longitudinally. While only
A' velocity was increased in ESRD+DM group, PSV and SR
were increased in the ESRD+DM+CAD group (data not
shown). A significant decrease in IVCT (79.50 ± 29.14
msec vs. 63.14 ± 16.39 msec, p < 0.05) after HD was
observed in the latter group as well. E'/A' ratio was signif-
Global longitudinal strain rate measured pre- and post-hemo-dialysisFigure 3
Global longitudinal strain rate measured pre- and post-hemo-
dialysis. * p < 0.001 for within-group paired comparisons 
between pre-and post-HD. Data represent average values of 
















Table 3: 2-D Echocardiography data, body weight and blood pressure measurements pre- and post-hemodialysis
ESRD (Group 1) ESRD+DM (Group 2) ESRD+DM+CAD (Group 3)
PRE POST PRE POST PRE POST
Weight (kg) 51 ± 9 48 ± 8* 62 ± 10 59 ± 10* 61 ± 9 58 ± 9*
R-R interval(ms) 705 ± 137 683 ± 207 707 ± 122 683 ± 134 701 ± 92 714 ± 118
Systolic BP (mm of Hg) 145 ± 26 136 ± 20 147 ± 11 140 ± 16 147 ± 21 139 ± 14
Diastolic BP (mm of Hg) 86 ± 40 83 ± 9 83 ± 5 81 ± 5 83 ± 9 79 ± 9
IVSd (mm) 12 ± 3 13 ± 2 12 ± 2 12 ± 2 12 ± 2 12 ± 2
LVPWd (mm) 11 ± 3 11 ± 2 11 ± 2 10 ± 1 11 ± 1 11 ± 2
LVIDd (mm) 46 ± 5 42 ± 7* 53 ± 7 50 ± 7* 51 ± 7 47 ± 8*
LVEF (%) 53 ± 13 54 ± 13 49 ± 13 48 ± 13 43 ± 11 46 ± 10
Mitral E (cm/s) 130 ± 32 103 ± 28† 116 ± 32 105 ± 26 127 ± 23 84 ± 20*
Mitral A (cm/s) 99 ± 45 102 ± 34 79 ± 33 94 ± 38 93 ± 21 101 ± 26
E/A Ratio 1.5 ± 0.5 1.1 ± 0.4† 1.8 ± 1 1.4 ± 1‡ 1.5 ± 0.6 0.9 ± 0.2‡
DT (ms) 108 ± 34 116 ± 42 115 ± 28 116 ± 34 131 ± 41 177 ± 60†
Data are means ± SD. Within group comparisons were made using paired 't' test. * p < 0.05;† p < 0.01;‡p < 0.001. IVSd = Interventricular septum in 
diastole; PWDd = Posterior wall thickness in diastole; LVIDd = Left ventricular internal diameter in diastole; DT = Decelaration time of E velocity. 
LVEF= Left ventricular ejection fraction.Page 5 of 9
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ation, and filling times as well as LV displacement showed
no significant differences.
Systolic and diastolic time intervals, LV filling variables and 
Tei index
Measurement of IVCT, ET, IVRT and FT at pre- HD did not
differ. ESRD group at post- HD showed global and
regional decrease of ejection time (ET) in all the LV walls
(data not shown). In the ESRD+DM group filling time was
decreased only in septum, while in the ESRD+DM+CAD
group there was global and regional decrease in ET in sep-
tum, lateral and anterior wall. Isovolumic relaxation time
(IVRT) was however prolonged globally after HD (73.55
± 9.87 msec vs. 101.42 ± 19.55 msec; p < 0.001) in the
same group. On the other hand, isovolumic contraction
time (IVCT) did not show any significant changes.
LV filling pressures were assessed indirectly by calculating
E/E' ratio at the septal and lateral annulus, pre- and post-
HD. At pre-HD, there were no significant differences
among the groups (data not shown). There was however
a decrease in E/E' ratio at post-HD only in the ESRD group
when measured separately and also when the average of
the two walls was done (23.28 ± 15.85 vs. 14.42 ± 8.84; p
< 0.05).
LV Global Tei index was significantly higher after HD
(0.67 ± 0.22) than before (0.57 ± 0.10 vs.;p < 0.05) in
Group 1 and in Group 3 (0.72 ± 015 vs. 0.54 ± 0.10; p <
Table 4: Comparisons of the left ventricular regional TVE parameters pre- (upper panel) and post- HD (lower panel). Data are mean ± 
SD
Groups & LV bases PSV E' cm/s A' cm/s Disp.mm
ESRD
Septum 5.7 ± 1.6 -5.7 ± 1.9 -6.4 ± 3.5 8.9 ± 3.2
Lateral 5.9 ± 2.7* -8.4 ± 3.6 -10.4 ± 4.0§ 8.1 ± 3.7
Inferior 6.6 ± 1.4† -8.9 ± 3.5#¶ -5.9 ± 2.3 11.2 ± 3.3**
Anterior 7.1 ± 1.9‡ -8.4 ± 3.3#¶ -5.4 ± 3.1 9.4 ± 2.3††
ESRD+DM
Septum 4.7 ± 1.5 -5.1 ± 1.5 -5.6 ± 3.1 7.4 ± 2.2
Lateral 4.5 ± 1.4 -6.3 ± 2.1 -5.0 ± 3.3 5.7 ± 2.6
Inferior 4.9 ± 1.1 -5.4 ± 1.8 -7.1 ± 3.0 9.0 ± 3.5
Anterior 4.8 ± 1.4 -4.4 ± 1.6 -5.2 ± 2.9 6.5 ± 2.7
ESRD+DM+CAD
Septum 4.6 ± 1.1 -5.5 ± 1.5 -6.0 ± 2.6 6.8 ± 2.4
Lateral 3.9 ± 1.1 -6.5 ± 2.5 -3.6 ± 1.6 5.4 ± 2.2
Inferior 4.9 ± 1.4 -5.9 ± 1.3 -7.1 ± 2.4 8.2 ± 2.3
Anterior 4.4 ± 1.1 -5.9 ± 1.9 -4.9 ± 3.3 6.3 ± 1.7
ESRD Post Hemodialysis data
Septum 7.2 ± 2.3*† -7.5 ± 2.1‡# -8.9 ± 3.5¶ 7.7 ± 3.4§
Lateral 7.8 ± 3.8 -10.2 ± 4.0 -11.5 ± 4.0 7.6 ± 3.8
Inferior 7.9 ± 2.1 -9.9 ± 3.4 -8.1 ± 3.2 8.8 ± 3.6
Anterior 8.6 ± 2.1 -9.9 ± 3.3 -7.7 ± 3.9 8.0 ± 2.9
ESRD+DM 
Septum 5.2 ± 1.3 -4.6 ± 1.0 -8.1 ± 3.1 7.0 ± 2.4
Lateral 4.9 ± 1.3 -6.6 ± 2.5 -6.5 ± 4.2 6.2 ± 2.7
Inferior 5.2 ± 1.6 -5.5 ± 2.7 -8.3 ± 3.1 9.2 ± 3.8
Anterior 5.0 ± 1.5 -4.9 ± 1.7 -6.13 ± 3.1 5.7 ± 1.9
ESRD+DM+CAD
Septum 4.1 ± 1.3 -3.8 ± 2.5 -5.5 ± 2.1 4.7 ± 1.8
Lateral 4.3 ± 1.7 -5.1 ± 2.3 -3.5 ± 2.2 5.8 ± 2.4
Inferior 4.6 ± 1.1 -4.1 ± 2.1 -7.8 ± 2.4 7.1 ± 2.6
Anterior 4.9 ± 1.3 -3.9 ± 2.4 -5.7 ± 2.4 5.6 ± 2.3
Pre-HD comparisons: *p < 0.05, † p < 0.01, †† p < 0.001,§ p < 0.001,††p < 0.01 vs. other 2 groups.#p < 0.001 vs. Group 2. ¶p < 0.05 vs. Group3. 
**p < 0.05 vs. ESRD+DM+CAD. Post-HD comparisons: * p < 0.05 vs. Group 2 and Group 3; † p < 0.01 vs. Group 2 and Group 3; ‡ p < 0.01 vs. 
Group 2 and Group 3 ; #p < 0.001 vs. Group 2 and Group 3; ¶p < 0.05 vs. Group3; § p < 0.05 vs. Group 3 (all comparisons in septum); PSV = peak 
myocardial systolic velocity; E' = early myocardial diastolic velocity; A' = late myocardial diastolic velocity; Disp = displacement. Group comparisons 
(pre- and post- HD) were made using one- way ANOVA followed by Scheffe's test.Page 6 of 9
(page number not for citation purposes)
Cardiovascular Ultrasound 2006, 4:9 http://www.cardiovascularultrasound.com/content/4/1/90.001), while remained unchanged in Group 2 (0.72 ±
0.15 vs. 0.61 ± 0.14.; p = ns).
Discussion
The principal findings of the study are: firstly, global left
ventricular longitudinal systolic and diastolic myocardial
velocities and systolic strain rate become higher in ESRD
group post-HD; secondly, these variables are either
unchanged or even become worse (E' velocity in Group 3,
vide Figure 2) in the other 2 groups; thirdly, radial veloci-
ties and strain rate also becomes higher in ESRD while
minimal compensatory over-activities of the radial systo-
lic functions (velocity and strain rate) are noted in the
ESRD+DM+CAD groups. Finally, despite significant
reduction in dialysis-dependent preload, LV filling pres-
sures, as assessed by E/E' ratio, decreased only in ESRD
group, indicating that acute changes in loading conditions
influence the TVE variables in a different way depending
on the background diseases.
The improved LV functions in ESRD groups in the present
study confirm the findings reported by others [17,18] and
could be explained by the fact that there is improved myo-
cardial perfusion, which is not only because of removal of
fluids, solutes and toxins [19], but also because of
improvement in myocardial interstitial oedema [20].
Another reason that can be attributed to this improve-
ment is that LV hypertrophy was not seen in this group as
frequently as in the other 2 groups. A modest increase in
Tei index was however observed in this group of patients
post HD, suggesting somewhat decreased myocardial per-
formance, not uncommonly seen even in even patients
with isolated ESRD [21]. However, the absolute value was
far below then the threshold of 0.91 seen in patients with
heart failure [22].
A subtle form of diabetic heart muscle disease is recogniz-
able by TVE at rest as has been shown by Fang ZY et al
[10], possibly reflecting microvascular disease in the earli-
est form of diabetic cardiomyopathy [23], since stress
velocity response was normal. Moreover, it has been
reported that the patients with ESRD + DM and angio-
graphically normal coronary arteries have a lower coro-
nary flow reserve (CFR) than patients with DM alone [24].
Decreased lumen area, vascular remodeling and increased
LV mass may explain this attenuated CFR. These mecha-
nisms are often related to microvascular disease of DM,
hypertensive heart disease, and CAD [25,26], and may
have influenced the current post-HD data in the groups
with concomitant DM and CAD. In addition, when diabe-
tes is associated with significant coronary disease the LV
myocardial velocities progressively decrease [11]. It is
therefore not surprising that in patients with
ESRD+DM+CAD had additional disturbances, such as
prolonged IVRT, diminished systolic displacement,
unchanged LV filing pressures and significantly higher Tei
index post HD
Global longitudinal myocardial systolic (PSV), early (E') and late diastolic (A') velocities, pre- and post-hemodialysisFigure 2
Global longitudinal myocardial systolic (PSV), early (E') and 
late diastolic (A') velocities, pre- and post-hemodialysis. † p < 
0.01; ‡ p < 0.001. Results were obtained by taking average of 
4 left ventricular basal segments pre- (closed symbols) and 
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A single HD session improves LV functions in ESRD only
in absence of co-morbidities. In presence of DM, myocar-
dial functions continue to remain diminished irrespective
of concomitant CAD. Minor compensatory over-activity
of systolic radial motion can be seen in the latter group,
possibly because of the general regional nature of CAD.
Our data suggest that the observed HD-induced differ-
ences in TVE variables by and large depend on the preex-
istent myocardial functional status and associated
hemodynamic milieu during the time of investigation.
Study limitations
The younger age in the ESRD group could have influenced
the increase in systolic and diastolic velocities and strain
rate. However, published data from our group as well as
those from others indicate that presence of DM and CAD
has ominous effects on LV functions irrespective of age.
We therefore believe that the age differences have not
influenced the obtained results. We have studied only one
randomly chosen HD session and hence it is difficult to
reflect on the natural history of progression of LV dysfunc-
tion in these patients.
Clinical implications
In patients undergoing maintenance HD the hemody-
namic status is in a state of constant flux. There is no well-
established technique to quantitatively monitor serial
changes of myocardial functions in patients with ESRD
undergoing periodic HD. However, the results of the
present study have shown that in contrast to standard
Doppler, TVE offers a unique choice to extensively study
myocardial functional differences resulting from dialysis-
dependant preload changes and the procedure may be of
importance in following patients with associated DM
and/or CAD in the setting of ESRD. At the same time the
ESRD subjects may also offer a unique opportunity to
study influence of loading conditions clinically by appli-
cation of TVE methods that are more robust and perhaps
less load- dependent than conventional Doppler methods
at least within physiological limits.
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